No Detail Found!

Post-vaccination (COVID-19) impacts in healthcare personnel

Author(s)
Saman Shahid Department of Sciences & Humanities, National University of Computer & Emerging Sciences (NUCES), FAST Lahore Campus, Pakistan
Aysha Ghayyur Medical Unit -II, Lahore General Hospital (LGH),Lahore,Pakistan
Asma Majeed Department of Environmental Science, Faculty of Agriculture & Environment, The Islamia University of Bahawalpur, Pakistan
Subhana Nisar Forman Christian College (FCC)- A Chartered University, Lahore, Pakistan; Integrated Engineering Centre of Excellence (IECE), The University of Lahore, Pakistan
Muhammad Anwar Chaudary Department of Neurosurgery, Punjab Institute of Neurosciences (PINS), Lahore General Hospital (LGH),Lahore,Pakistan
Abstract
The COVID-19 pandemic has brought attention back to its spread in medical staff. A survey-based study was conducted to combine general information related to COVID-19 exposures, acceptances, vaccines received, and side effects. The majority (62.3%) of healthcare professionals had acquired COVID-19 infection from hospital environment (51.5%) mainly who treated (64%) COVID-19 patients. 54% healthcare respondents expressed 'high acceptance' towards COVID-19 vaccines. 88% received COVID-19 vaccination. The majority of healthcare personnel received SinoPharm (65%). 82.3% did not acquire COVID-19 post-vaccination. 38% mild side effects were observed from vaccination. Following were the general side-effects: myalgia (18.2%), the feeling of sickness (16%), fever (15.6%), dizziness (7.8%), joint pain (7.4%), chills (4.8%), and flu (4.8%). Following were the common neurological side-effects reported: headache (18.2%), fatigue (16.5%), muscle pain (16%), numbness/tingling (3%), and migraine (2.6%). Nausea and diarrhoea were reported in only 3.5% of respondents. Bad taste was reported in only 3% of respondents. The 1.7% reported rash and itching. The majority of the healthcare professionals did not report significant side effects related to neurological, gastroenterological, skin and oral categories. To assess the vaccines' potential for substantial and longterm or chronic effects, more study with a larger sample size and a longer follow-up time is required.
Publication Details
Page(s) 1957-1962
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP5, Year: 2021

Request the full text from PASTIC

Keywords
Muscle, SinoPharm, Headache, Healthcare Professionals, Myalgia, Fever, COVID-19 Vaccines
References
Abu-Hammad O,Alduraidi H,Abu-Hammad S,Alnazzawi A,Babkair H,Abu-Hammad A,Nourwali I,Qasem F,Dar-Odeh N .2021 .Side Effects reported by Jordanian healthcare workers who received COVID-19 vaccines. , 9(6) : 577.
Abu-Raddad LJ,Chemaitelly H,Coyle P,Malek JA,Ahmed AA,Mohamoud YA,Younuskunju S,Ayoub HH,Al Kuwari Z,Butt E,AA E .2021 .SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. E. Clinical Medicine, 1(35) : 100861.
Baraniuk C .2021 .What do we know about China's covid-. vaccines? BMJ, 9 : 373.
Chigevenga R .2021 .Commentary on the Zimbabwean people's response towards the anticipated COVID-19 vaccine. J. Biomed Res. Environ. Sci, 2(3) : 174-177.
Chung YH,Beiss V,Fiering SN,Steinmetz NF .2020 .COVID-19 vaccine frontrunners and their nanotechnology design. ACS Nano, 14(10) : 12522-37.
Doroftei B,Ciobica A,Ilie OD,Maftei R,Ilea C .2021 .Mini-review discussing the reliability and efficiency of COVID-19 vaccines. , 11(4) : 579.
El-Shitany NA,Harakeh S,Badr-Eldin SM,Bagher AM,Eid B,Almukadi H,Alghamdi BS,Alahmadi AA,Hassan NA,Sindi N,Alghamdi SA .2021 .Minor to moderate side effects of Pfizer-BioNTech COVID19 vaccine among Saudi residents: A retrospective cross-sectional study. Int. J. Gen. Med, 14 : 1389.
Feng A,Tobe RG,Wang Y,Yang T,Mo X,Zhao L .2021 .Safety monitoring of COVID vaccines and perception of post-vaccination side-effects: Preliminary findings from. The first month of routine monitoring in a hospital vaccination setting of China. , : 1-9.
Scorza Finsterer J,FA Finsterer J .2021 .SARS‐CoV‐2 vaccines are not free of neurological side effects. Acta Neurol, 144(1) : 109.
Hatmal MM,Al-Hatamleh MA,Olaimat AN,Hatmal M,Alhaj-Qasem DM,Olaimat TM,Mohamud R .2021 .Side effects and perceptions following COVID19 vaccination in Jordan: A randomized, crosssectional study implementing machine learning for predicting severity of side effects. Vaccines, 9(6) : 556.
Hiller N,Goldberg SN,Cohen-Cymberknoh M,Vainstein V,Simanovsky N V .2021 .Lymphadenopathy associated with the COVID-19 vaccine. , 13(2) : e13524.
Jęśkowiak I,Wiatrak B,Grosman-Dziewiszek P,Szeląg A .2021 .The incidence and severity of postvaccination reactions after vaccination against COVID19. , 9(5) : 502.
Kose S,Mandiracioglu A,Sahin S,Kaynar T,Karbus O,Ozbel Y .2021 .Vaccine hesitancy of the COVID-19 by health care personnel. Int. J. Clin. Practice, 75(5) : e13917.
Kwok KO,Li KK,Wei WI,Tang A,Wong SY,Lee SS .2021 .Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. Int. J. Nurs. Studies, 114 : 103854.
Lazarus JV,Ratzan SC,Palayew A,Gostin LO,Larson HJ,Rabin K,Kimball S,El-Mohandes A .2021 .A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med, 27(2) : 225-228.
Letizia AG,Ge Y,Vangeti S,Goforth C,Weir DL,Kuzmina NA,Balinsky CA,Chen HW,Ewing D,Soares-Schanoski A,George MC .2021 .SARSCoV-2 seropositivity and subsequent infection risk in healthy young adults: A prospective cohort study. Lancet Respirat Med, 9 : 712-720.
Papagiannis D,Rachiotis G,Malli F,Papathanasiou IV,Kotsiou O,Fradelos EC,Giannakopoulos K,Gourgoulianis KI K .2021 .Acceptability of COVID-19 vaccination among Greek health professionals. Vaccines., 9(3) : 200.
Pormohammad A,Zarei M,Ghorbani S,Mohammadi M,Razizadeh MH,Turner DL,Turner RJ .2021 .Efficacy and safety of COVID-19 Vaccines: A systematic review and meta-analysis of randomized clinical trials. Vaccines, 9(5) : 467.
Salmon DA,Dudley MZ,Brewer J,Kan L,Gerber JE,Budigan H,Proveaux TM,Bernier R,Rimal R,Schwartz B .2021 .COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization. Vaccine, 39(19) : 2698-2711.
Schwarzinger M,Watson V,Arwidson P,Alla F,Luchini S .2021 .COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics. Lancet Public Health, 6(4) : e210-21.
Sherman SM,Smith LE,Sim J,Amlôt R,Cutts M,Dasch H,Rubin GJ,Sevdalis N GJ .2021 .COVID-19 vaccination intention in the UK: Results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum. Vaccines Immunother, 17(6) : 1612-1621.
Waheed S,Bayas A,Hindi F,Espinosa Rizvi Z,PS Rizvi Z .2021 .Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. , 13(2) : 1-4.
Wong MC,Wong EL,Huang J,Cheung AW,Law K,Chong MK,Ng RW,Lai CK,Boon SS,Lau JT,Chen Z JT .2021 .Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. , 39(7) : 1148-1156.
0

Citations

0

Downloads

11

Views